nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—ALB—acquired immunodeficiency syndrome	0.265	1	CbGaD
Prasugrel—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0335	0.0575	CbGbCtD
Prasugrel—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0315	0.054	CbGbCtD
Prasugrel—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0315	0.054	CbGbCtD
Prasugrel—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0285	0.0489	CbGbCtD
Prasugrel—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0239	0.041	CbGbCtD
Prasugrel—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0216	0.037	CbGbCtD
Prasugrel—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0213	0.0365	CbGbCtD
Prasugrel—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0212	0.0363	CbGbCtD
Prasugrel—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0203	0.0348	CbGbCtD
Prasugrel—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.02	0.0343	CbGbCtD
Prasugrel—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0181	0.0311	CbGbCtD
Prasugrel—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0181	0.0311	CbGbCtD
Prasugrel—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0177	0.0304	CbGbCtD
Prasugrel—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0167	0.0285	CbGbCtD
Prasugrel—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0167	0.0285	CbGbCtD
Prasugrel—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0156	0.0268	CbGbCtD
Prasugrel—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0152	0.026	CbGbCtD
Prasugrel—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0151	0.0258	CbGbCtD
Prasugrel—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0151	0.0258	CbGbCtD
Prasugrel—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0137	0.0235	CbGbCtD
Prasugrel—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0137	0.0235	CbGbCtD
Prasugrel—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0132	0.0226	CbGbCtD
Prasugrel—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.013	0.0223	CbGbCtD
Prasugrel—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0126	0.0216	CbGbCtD
Prasugrel—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0114	0.0196	CbGbCtD
Prasugrel—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0114	0.0196	CbGbCtD
Prasugrel—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0109	0.0188	CbGbCtD
Prasugrel—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0103	0.0177	CbGbCtD
Prasugrel—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00969	0.0166	CbGbCtD
Prasugrel—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00969	0.0166	CbGbCtD
Prasugrel—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00876	0.015	CbGbCtD
Prasugrel—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00876	0.015	CbGbCtD
Prasugrel—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00756	0.013	CbGbCtD
Prasugrel—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00734	0.0126	CbGbCtD
Prasugrel—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00664	0.0114	CbGbCtD
Prasugrel—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00664	0.0114	CbGbCtD
Prasugrel—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00637	0.0109	CbGbCtD
Prasugrel—P2RY12—blood plasma—acquired immunodeficiency syndrome	0.00455	0.136	CbGeAlD
Prasugrel—P2RY12—blood—acquired immunodeficiency syndrome	0.00167	0.0497	CbGeAlD
Prasugrel—CES2—retina—acquired immunodeficiency syndrome	0.00159	0.0474	CbGeAlD
Prasugrel—CES2—skin of body—acquired immunodeficiency syndrome	0.0014	0.0416	CbGeAlD
Prasugrel—P2RY12—nervous system—acquired immunodeficiency syndrome	0.00135	0.0404	CbGeAlD
Prasugrel—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00134	0.0399	CbGeAlD
Prasugrel—P2RY12—central nervous system—acquired immunodeficiency syndrome	0.0013	0.0389	CbGeAlD
Prasugrel—CES2—digestive system—acquired immunodeficiency syndrome	0.00112	0.0333	CbGeAlD
Prasugrel—CES2—blood—acquired immunodeficiency syndrome	0.00106	0.0317	CbGeAlD
Prasugrel—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.00105	0.0312	CbGeAlD
Prasugrel—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00104	0.0309	CbGeAlD
Prasugrel—P2RY12—brain—acquired immunodeficiency syndrome	0.00103	0.0309	CbGeAlD
Prasugrel—CES2—bone marrow—acquired immunodeficiency syndrome	0.00103	0.0307	CbGeAlD
Prasugrel—CES2—spinal cord—acquired immunodeficiency syndrome	0.00102	0.0306	CbGeAlD
Prasugrel—CES2—vagina—acquired immunodeficiency syndrome	0.000986	0.0294	CbGeAlD
Prasugrel—CES2—lung—acquired immunodeficiency syndrome	0.000932	0.0278	CbGeAlD
Prasugrel—CES2—nervous system—acquired immunodeficiency syndrome	0.000863	0.0258	CbGeAlD
Prasugrel—CES2—central nervous system—acquired immunodeficiency syndrome	0.000831	0.0248	CbGeAlD
Prasugrel—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000791	0.0236	CbGeAlD
Prasugrel—CES2—brain—acquired immunodeficiency syndrome	0.00066	0.0197	CbGeAlD
Prasugrel—CES2—lymph node—acquired immunodeficiency syndrome	0.000638	0.019	CbGeAlD
Prasugrel—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000514	0.0153	CbGeAlD
Prasugrel—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000504	0.015	CbGeAlD
Prasugrel—CYP2C19—blood—acquired immunodeficiency syndrome	0.00049	0.0146	CbGeAlD
Prasugrel—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000454	0.0136	CbGeAlD
Prasugrel—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000408	0.0122	CbGeAlD
Prasugrel—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000403	0.012	CbGeAlD
Prasugrel—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000399	0.0119	CbGeAlD
Prasugrel—CYP2B6—blood—acquired immunodeficiency syndrome	0.000384	0.0114	CbGeAlD
Prasugrel—CYP2C9—blood—acquired immunodeficiency syndrome	0.00038	0.0113	CbGeAlD
Prasugrel—ALB—brain—acquired immunodeficiency syndrome	0.000378	0.0113	CbGeAlD
Prasugrel—ALB—lymph node—acquired immunodeficiency syndrome	0.000365	0.0109	CbGeAlD
Prasugrel—Oedema peripheral—Efavirenz—acquired immunodeficiency syndrome	0.000356	0.00301	CcSEcCtD
Prasugrel—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000356	0.0106	CbGeAlD
Prasugrel—Urethral disorder—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.003	CcSEcCtD
Prasugrel—Cough—Abacavir—acquired immunodeficiency syndrome	0.000354	0.00299	CcSEcCtD
Prasugrel—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.000352	0.00298	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00035	0.00295	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000349	0.00295	CcSEcCtD
Prasugrel—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.000348	0.00294	CcSEcCtD
Prasugrel—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.000347	0.00293	CcSEcCtD
Prasugrel—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00292	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000343	0.0029	CcSEcCtD
Prasugrel—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000341	0.00288	CcSEcCtD
Prasugrel—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.00288	CcSEcCtD
Prasugrel—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00287	CcSEcCtD
Prasugrel—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000338	0.00286	CcSEcCtD
Prasugrel—Eye disorder—Efavirenz—acquired immunodeficiency syndrome	0.000338	0.00286	CcSEcCtD
Prasugrel—CYP2B6—lung—acquired immunodeficiency syndrome	0.000336	0.01	CbGeAlD
Prasugrel—Epistaxis—Ritonavir—acquired immunodeficiency syndrome	0.000336	0.00284	CcSEcCtD
Prasugrel—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.000331	0.0028	CcSEcCtD
Prasugrel—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000331	0.0028	CcSEcCtD
Prasugrel—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00033	0.00279	CcSEcCtD
Prasugrel—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000329	0.00278	CcSEcCtD
Prasugrel—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000328	0.00277	CcSEcCtD
Prasugrel—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000328	0.00277	CcSEcCtD
Prasugrel—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000327	0.00277	CcSEcCtD
Prasugrel—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000327	0.00276	CcSEcCtD
Prasugrel—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00276	CcSEcCtD
Prasugrel—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000326	0.00275	CcSEcCtD
Prasugrel—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000324	0.00274	CcSEcCtD
Prasugrel—Epistaxis—Saquinavir—acquired immunodeficiency syndrome	0.000324	0.00273	CcSEcCtD
Prasugrel—Back pain—Indinavir—acquired immunodeficiency syndrome	0.000322	0.00272	CcSEcCtD
Prasugrel—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000322	0.00272	CcSEcCtD
Prasugrel—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00272	CcSEcCtD
Prasugrel—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000321	0.00271	CcSEcCtD
Prasugrel—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.0027	CcSEcCtD
Prasugrel—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00267	CcSEcCtD
Prasugrel—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.00266	CcSEcCtD
Prasugrel—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.00265	CcSEcCtD
Prasugrel—Cough—Zidovudine—acquired immunodeficiency syndrome	0.000313	0.00264	CcSEcCtD
Prasugrel—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000312	0.00929	CbGeAlD
Prasugrel—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00031	0.00262	CcSEcCtD
Prasugrel—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.00262	CcSEcCtD
Prasugrel—Epistaxis—Lamivudine—acquired immunodeficiency syndrome	0.000309	0.00261	CcSEcCtD
Prasugrel—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.0026	CcSEcCtD
Prasugrel—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000308	0.0026	CcSEcCtD
Prasugrel—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000306	0.00259	CcSEcCtD
Prasugrel—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000305	0.00258	CcSEcCtD
Prasugrel—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00257	CcSEcCtD
Prasugrel—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000304	0.00257	CcSEcCtD
Prasugrel—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000304	0.00907	CbGeAlD
Prasugrel—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00257	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000303	0.00256	CcSEcCtD
Prasugrel—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00255	CcSEcCtD
Prasugrel—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000301	0.00254	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000301	0.00254	CcSEcCtD
Prasugrel—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.0003	0.00254	CcSEcCtD
Prasugrel—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.0003	0.00895	CbGeAlD
Prasugrel—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.00253	CcSEcCtD
Prasugrel—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000295	0.0025	CcSEcCtD
Prasugrel—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000292	0.00247	CcSEcCtD
Prasugrel—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000291	0.00246	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000291	0.00246	CcSEcCtD
Prasugrel—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000291	0.00246	CcSEcCtD
Prasugrel—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000291	0.00246	CcSEcCtD
Prasugrel—Cough—Indinavir—acquired immunodeficiency syndrome	0.000291	0.00246	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00029	0.00245	CcSEcCtD
Prasugrel—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00245	CcSEcCtD
Prasugrel—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00029	0.00245	CcSEcCtD
Prasugrel—CYP3A4—blood—acquired immunodeficiency syndrome	0.00029	0.00864	CbGeAlD
Prasugrel—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.00244	CcSEcCtD
Prasugrel—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000288	0.00244	CcSEcCtD
Prasugrel—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.00243	CcSEcCtD
Prasugrel—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.00243	CcSEcCtD
Prasugrel—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000286	0.00242	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000286	0.00242	CcSEcCtD
Prasugrel—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000286	0.00241	CcSEcCtD
Prasugrel—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000285	0.00241	CcSEcCtD
Prasugrel—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000284	0.0024	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000282	0.00238	CcSEcCtD
Prasugrel—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00236	CcSEcCtD
Prasugrel—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.00235	CcSEcCtD
Prasugrel—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.00235	CcSEcCtD
Prasugrel—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000278	0.00235	CcSEcCtD
Prasugrel—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.00235	CcSEcCtD
Prasugrel—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000275	0.00233	CcSEcCtD
Prasugrel—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000275	0.00233	CcSEcCtD
Prasugrel—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000275	0.00232	CcSEcCtD
Prasugrel—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000272	0.0023	CcSEcCtD
Prasugrel—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.0023	CcSEcCtD
Prasugrel—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00228	CcSEcCtD
Prasugrel—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.00228	CcSEcCtD
Prasugrel—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000268	0.00226	CcSEcCtD
Prasugrel—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000268	0.00226	CcSEcCtD
Prasugrel—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000267	0.00225	CcSEcCtD
Prasugrel—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000266	0.00225	CcSEcCtD
Prasugrel—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000266	0.00225	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000266	0.00225	CcSEcCtD
Prasugrel—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000266	0.00225	CcSEcCtD
Prasugrel—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00224	CcSEcCtD
Prasugrel—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000265	0.00224	CcSEcCtD
Prasugrel—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00224	CcSEcCtD
Prasugrel—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000264	0.00223	CcSEcCtD
Prasugrel—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00222	CcSEcCtD
Prasugrel—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000262	0.00221	CcSEcCtD
Prasugrel—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000261	0.0022	CcSEcCtD
Prasugrel—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.0022	CcSEcCtD
Prasugrel—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.00219	CcSEcCtD
Prasugrel—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.00218	CcSEcCtD
Prasugrel—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000257	0.00217	CcSEcCtD
Prasugrel—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000252	0.00213	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000252	0.00213	CcSEcCtD
Prasugrel—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000252	0.00213	CcSEcCtD
Prasugrel—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000252	0.00213	CcSEcCtD
Prasugrel—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00025	0.00211	CcSEcCtD
Prasugrel—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.00211	CcSEcCtD
Prasugrel—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.00211	CcSEcCtD
Prasugrel—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000249	0.0021	CcSEcCtD
Prasugrel—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000248	0.00209	CcSEcCtD
Prasugrel—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00209	CcSEcCtD
Prasugrel—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.00209	CcSEcCtD
Prasugrel—Rash—Didanosine—acquired immunodeficiency syndrome	0.000244	0.00206	CcSEcCtD
Prasugrel—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000244	0.00206	CcSEcCtD
Prasugrel—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000244	0.00206	CcSEcCtD
Prasugrel—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00205	CcSEcCtD
Prasugrel—Headache—Didanosine—acquired immunodeficiency syndrome	0.000243	0.00205	CcSEcCtD
Prasugrel—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000242	0.00205	CcSEcCtD
Prasugrel—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000242	0.00205	CcSEcCtD
Prasugrel—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000241	0.00204	CcSEcCtD
Prasugrel—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.00203	CcSEcCtD
Prasugrel—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00203	CcSEcCtD
Prasugrel—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.00203	CcSEcCtD
Prasugrel—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.00202	CcSEcCtD
Prasugrel—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000238	0.00201	CcSEcCtD
Prasugrel—CYP2B6—brain—acquired immunodeficiency syndrome	0.000238	0.0071	CbGeAlD
Prasugrel—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000238	0.00201	CcSEcCtD
Prasugrel—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.002	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.00199	CcSEcCtD
Prasugrel—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000235	0.00702	CbGeAlD
Prasugrel—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000235	0.00198	CcSEcCtD
Prasugrel—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000234	0.00198	CcSEcCtD
Prasugrel—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00198	CcSEcCtD
Prasugrel—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.00197	CcSEcCtD
Prasugrel—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00196	CcSEcCtD
Prasugrel—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000231	0.00195	CcSEcCtD
Prasugrel—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000231	0.00195	CcSEcCtD
Prasugrel—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00023	0.00195	CcSEcCtD
Prasugrel—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00023	0.00194	CcSEcCtD
Prasugrel—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00194	CcSEcCtD
Prasugrel—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000229	0.00194	CcSEcCtD
Prasugrel—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.00193	CcSEcCtD
Prasugrel—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000227	0.00192	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.00192	CcSEcCtD
Prasugrel—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000226	0.00676	CbGeAlD
Prasugrel—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00189	CcSEcCtD
Prasugrel—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000223	0.00189	CcSEcCtD
Prasugrel—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.00188	CcSEcCtD
Prasugrel—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000222	0.00188	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.00187	CcSEcCtD
Prasugrel—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.00187	CcSEcCtD
Prasugrel—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00187	CcSEcCtD
Prasugrel—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00022	0.00186	CcSEcCtD
Prasugrel—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000219	0.00185	CcSEcCtD
Prasugrel—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000219	0.00185	CcSEcCtD
Prasugrel—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000219	0.00185	CcSEcCtD
Prasugrel—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000218	0.00184	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.00183	CcSEcCtD
Prasugrel—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000215	0.00182	CcSEcCtD
Prasugrel—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.00181	CcSEcCtD
Prasugrel—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000213	0.0018	CcSEcCtD
Prasugrel—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000213	0.0018	CcSEcCtD
Prasugrel—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.0018	CcSEcCtD
Prasugrel—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.0018	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.00179	CcSEcCtD
Prasugrel—Rash—Stavudine—acquired immunodeficiency syndrome	0.000212	0.00179	CcSEcCtD
Prasugrel—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.00179	CcSEcCtD
Prasugrel—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000212	0.00179	CcSEcCtD
Prasugrel—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000211	0.00179	CcSEcCtD
Prasugrel—Headache—Stavudine—acquired immunodeficiency syndrome	0.000211	0.00178	CcSEcCtD
Prasugrel—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00021	0.00177	CcSEcCtD
Prasugrel—Rash—Abacavir—acquired immunodeficiency syndrome	0.000209	0.00177	CcSEcCtD
Prasugrel—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000209	0.00176	CcSEcCtD
Prasugrel—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.00176	CcSEcCtD
Prasugrel—Headache—Abacavir—acquired immunodeficiency syndrome	0.000208	0.00175	CcSEcCtD
Prasugrel—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000207	0.00175	CcSEcCtD
Prasugrel—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.00173	CcSEcCtD
Prasugrel—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.00173	CcSEcCtD
Prasugrel—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.00172	CcSEcCtD
Prasugrel—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00171	CcSEcCtD
Prasugrel—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.00171	CcSEcCtD
Prasugrel—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.0002	0.00169	CcSEcCtD
Prasugrel—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.0002	0.00169	CcSEcCtD
Prasugrel—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.00169	CcSEcCtD
Prasugrel—Nausea—Stavudine—acquired immunodeficiency syndrome	0.0002	0.00169	CcSEcCtD
Prasugrel—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000197	0.00166	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.00166	CcSEcCtD
Prasugrel—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.00166	CcSEcCtD
Prasugrel—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000195	0.00165	CcSEcCtD
Prasugrel—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.00165	CcSEcCtD
Prasugrel—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00165	CcSEcCtD
Prasugrel—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.00164	CcSEcCtD
Prasugrel—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.00163	CcSEcCtD
Prasugrel—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.0016	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.0016	CcSEcCtD
Prasugrel—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.00159	CcSEcCtD
Prasugrel—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.00157	CcSEcCtD
Prasugrel—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000186	0.00157	CcSEcCtD
Prasugrel—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.00156	CcSEcCtD
Prasugrel—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.00156	CcSEcCtD
Prasugrel—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.00156	CcSEcCtD
Prasugrel—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.00155	CcSEcCtD
Prasugrel—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.00153	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.00152	CcSEcCtD
Prasugrel—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.00152	CcSEcCtD
Prasugrel—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00018	0.00152	CcSEcCtD
Prasugrel—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.00152	CcSEcCtD
Prasugrel—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.00149	CcSEcCtD
Prasugrel—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.00149	CcSEcCtD
Prasugrel—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.00147	CcSEcCtD
Prasugrel—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.00146	CcSEcCtD
Prasugrel—Rash—Indinavir—acquired immunodeficiency syndrome	0.000171	0.00145	CcSEcCtD
Prasugrel—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000171	0.00145	CcSEcCtD
Prasugrel—Headache—Indinavir—acquired immunodeficiency syndrome	0.00017	0.00144	CcSEcCtD
Prasugrel—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.00144	CcSEcCtD
Prasugrel—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.00142	CcSEcCtD
Prasugrel—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.00142	CcSEcCtD
Prasugrel—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.00139	CcSEcCtD
Prasugrel—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.00138	CcSEcCtD
Prasugrel—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.00137	CcSEcCtD
Prasugrel—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.00137	CcSEcCtD
Prasugrel—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.00137	CcSEcCtD
Prasugrel—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000162	0.00136	CcSEcCtD
Prasugrel—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.00136	CcSEcCtD
Prasugrel—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.00136	CcSEcCtD
Prasugrel—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00133	CcSEcCtD
Prasugrel—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.00131	CcSEcCtD
Prasugrel—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.00131	CcSEcCtD
Prasugrel—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.00131	CcSEcCtD
Prasugrel—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.0013	CcSEcCtD
Prasugrel—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.0013	CcSEcCtD
Prasugrel—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.00129	CcSEcCtD
Prasugrel—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.00127	CcSEcCtD
Prasugrel—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00127	CcSEcCtD
Prasugrel—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.00127	CcSEcCtD
Prasugrel—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.00123	CcSEcCtD
Prasugrel—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.00122	CcSEcCtD
Prasugrel—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00121	CcSEcCtD
Prasugrel—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00121	CcSEcCtD
Prasugrel—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.00121	CcSEcCtD
Prasugrel—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.0012	CcSEcCtD
Prasugrel—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00117	CcSEcCtD
Prasugrel—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.00117	CcSEcCtD
Prasugrel—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.00116	CcSEcCtD
Prasugrel—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.00116	CcSEcCtD
Prasugrel—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.00114	CcSEcCtD
Prasugrel—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.00111	CcSEcCtD
Prasugrel—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.00111	CcSEcCtD
Prasugrel—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.0011	CcSEcCtD
Prasugrel—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.0011	CcSEcCtD
Prasugrel—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.00105	CcSEcCtD
